Agios Pharmaceuticals Property, Plant, and Equipment 2012-2024 | AGIO
Agios Pharmaceuticals property, plant, and equipment from 2012 to 2024. Property, plant, and equipment can be defined as the sum of all net property, plant & Equipment fields. Where companies do not report a break down of plant, property, & equipment, the value is entered in this field alone.
| Agios Pharmaceuticals Annual Property, Plant, and Equipment (Millions of US $) |
|
|---|---|
| 2023 | $15 |
| 2022 | $23 |
| 2021 | $29 |
| 2020 | $31 |
| 2019 | $31 |
| 2018 | $24 |
| 2017 | $24 |
| 2016 | $25 |
| 2015 | $23 |
| 2014 | $6 |
| 2013 | $4 |
| 2012 | $4 |
| 2011 | $ |
| Agios Pharmaceuticals Quarterly Property, Plant, and Equipment (Millions of US $) |
|
|---|---|
| 2024-09-30 | $12 |
| 2024-06-30 | $13 |
| 2024-03-31 | $14 |
| 2023-12-31 | $15 |
| 2023-09-30 | $17 |
| 2023-06-30 | $20 |
| 2023-03-31 | $21 |
| 2022-12-31 | $23 |
| 2022-09-30 | $25 |
| 2022-06-30 | $27 |
| 2022-03-31 | $29 |
| 2021-12-31 | $29 |
| 2021-09-30 | $25 |
| 2021-06-30 | $27 |
| 2021-03-31 | $29 |
| 2020-12-31 | $31 |
| 2020-09-30 | $33 |
| 2020-06-30 | $34 |
| 2020-03-31 | $34 |
| 2019-12-31 | $31 |
| 2019-09-30 | $24 |
| 2019-06-30 | $23 |
| 2019-03-31 | $24 |
| 2018-12-31 | $24 |
| 2018-09-30 | $25 |
| 2018-06-30 | $24 |
| 2018-03-31 | $24 |
| 2017-12-31 | $24 |
| 2017-09-30 | $24 |
| 2017-06-30 | $25 |
| 2017-03-31 | $24 |
| 2016-12-31 | $25 |
| 2016-09-30 | $26 |
| 2016-06-30 | $25 |
| 2016-03-31 | $23 |
| 2015-12-31 | $23 |
| 2015-09-30 | $21 |
| 2015-06-30 | $19 |
| 2015-03-31 | $14 |
| 2014-12-31 | $6 |
| 2014-09-30 | $4 |
| 2014-06-30 | $3 |
| 2014-03-31 | $3 |
| 2013-12-31 | $4 |
| 2013-09-30 | $4 |
| 2013-06-30 | $4 |
| 2013-03-31 | |
| 2012-12-31 | |
| 2012-09-30 | |
| 2012-06-30 | |
| 2011-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $3.167B | $0.027B |
| Agios Pharmaceuticals, Inc. is a biopharmaceutical company focused on development of treatments for rare genetic metabolic disorders, a subset of orphan genetic metabolic diseases. | |||